Contrast-enhanced ultrasound predicts microvascular invasion in patients with hepatocellular carcinoma

doi:10.1016/j.hbpd.2022.05.008

Abstract
Figure/Table
References (0)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract The presence of microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an important indicator for HCC recurrence and poor prognosis [1]. Determining the preoperative MVI status is helpful for guiding clinical treatment and improving prognosis. Currently, MVI diagnosis is achieved primarily by postoperative histopathology, which makes it difficult to provide a definite diagnosis before surgery. However, significant advancements in imaging technology have begun to allow clinicians to make a diagnosis of HCC MVI prior to surgery. In this study, we used contrastenhanced ultrasound (CEUS) to observe the characteristics of HCC enhancement patterns and quantitatively analyze the changes in HCC blood perfusion parameters to explore the value of CEUS in evaluating HCC MVI.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles in this journal by
	Huang JY
	Huang ZL
	Yang Z
	Zheng XP

Cite this article:

Huang JY, Huang ZL, Yang Z, et al. Contrast-enhanced ultrasound predicts microvascular invasion in patients with hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2022; 21(6): 609-613. DOI:10.1016/j.hbpd.2022.05.008

URL:

http://dx.doi.org/10.1016/j.hbpd.2022.05.008 OR http://www.hbpdint.com/EN/Y2022/V21/I6/609